Combinaisons de thérapies anti-HER2: deux balles pour une même cible !GONCALVES, Anthony.Bulletin du cancer. 2012, Vol 99, Num 9, pp 813-814, issn 0007-4551, 2 p.Article

ErbB-2 (HER2, neu) : Oncogène = ErbB-2 (HER2, neu) : OncogeneBulletin du cancer. 1998, Vol 85, Num 8, issn 0007-4551, p. 671Article

Her-2/neu overexpression and amplification in uterine papillary serous carcinomaSLOMOVITZ, Brian M; BROADDUS, Russell R; BURKE, Thomas W et al.Journal of clinical oncology. 2004, Vol 22, Num 15, pp 3126-3132, issn 0732-183X, 7 p.Conference Paper

Surexpression de HER2: un dictat ? = Overexpression of HER2: a dictat?COTTU, P.Société Française de Sénologie et de Pathologie Mammaire. Journées. 2011, pp 168-173, isbn 978-2-8178-0248-0, 1Vol, 6 p.Conference Paper

Is HER2/neu expressed in nonepithelial ovarian malignancies?MENCZER, Joseph; SCHREIBER, Letizia; CZERNOBILSKY, Bernard et al.American journal of obstetrics and gynecology. 2007, Vol 196, Num 1, pp 79-80, issn 0002-9378, 2 p.Article

Targeting HER2 epitopesSUMANTA KUMAR PAL; PEGRAM, Mark.Seminars in oncology. 2006, Vol 33, Num 4, pp 386-391, issn 0093-7754, 6 p.Article

Downregulation of Muc1 in MMTV-c-Neu tumorsADRIANCE, Melissa C; GENDLER, Sandra J.Oncogene (Basingstoke). 2004, Vol 23, Num 3, pp 697-705, issn 0950-9232, 9 p.Article

The role of erbB-2 and its ligands in growth control of malignant breast epitheliumLUPU, R; DICKSON, R. B; LIPPMAN, M. E et al.Journal of steroid biochemistry and molecular biology. 1992, Vol 43, Num 1-3, pp 229-236, issn 0960-0760Conference Paper

Radionuclide therapy of HER2-positive microxenografts using a ¹⁷⁷Lu-labeled HER2-specific affibody moleculeTOLMACHEV, Vladimir; ORLOVA, Anna; WENNBORG, Anders et al.Cancer research (Baltimore). 2007, Vol 67, Num 6, pp 2773-2782, issn 0008-5472, 10 p.Article

erbB-2 overexpression but no activation of β-catenin gene in extramammary Paget's diseaseTAKATA, M; FUJIMOTO, A; AOKI, H et al.Journal of investigative dermatology. 1999, Vol 113, Num 2, pp 258-262, issn 0022-202XArticle

Increased level of c-erbB-2/neu/HER-2 protein in cutaneous squamous cell carcinomaAHMED, N. U; UEDA, M; ICHIHASHI, M et al.British journal of dermatology (1951). 1997, Vol 136, Num 6, pp 908-912, issn 0007-0963Article

Down-regulation of c-neu receptors by nerve growth factor in PC12 cellsOSHIMA, M; WEISS, L; DOUGALL, W. C et al.Journal of neurochemistry. 1995, Vol 65, Num 1, pp 427-433, issn 0022-3042Article

Assignment of heregulin (HGL) to human chromosome 8p22-p11 by PCR analysis of somatic cell hybrid DNALEE, J; WOOD, W. I.Genomics (San Diego, Calif.). 1993, Vol 16, Num 3, pp 790-791, issn 0888-7543Article

Par complex in cancer : a regulator of normal cell polarity joins the dark sideARANDA, V; NOLAN, M. E; MUTHUSWAMY, S. K et al.Oncogene (Basingstoke). 2008, Vol 27, Num 55, pp 6878-6887, issn 0950-9232, 10 p.Article

Modified direct-double-differential PCR for gene dosage quantification of HER2ZACZEK, Anna; WELNICKA-JASKIEWICZ, Marzena; BUERGER, Horst et al.Oncology reports. 2005, Vol 13, Num 5, pp 971-975, issn 1021-335X, 5 p.Article

Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary originPAVLIDIS, N; BRIASSOULIS, E; BAI, M et al.Anticancer research. 1995, Vol 15, Num 6B, pp 2563-2567, issn 0250-7005Article

Tumor-specific methylation patterns of erbB2 (HER2/neu) sequences in gastro-intestinal cancerHOLZMANN, K; WELTER, C; KLEIN, V et al.Anticancer research. 1992, Vol 12, Num 3, pp 1013-1018, issn 0250-7005Article

Characterization of the promoter region of the human c-erbB-2 protooncogeneISHII, S; IMAMOTO, F; YAMANASHI, Y et al.Proceedings of the National Academy of Sciences of the United States of America. 1987, Vol 84, Num 13, pp 4374-4378, issn 0027-8424Article

Two Dimensions in Targeting HER2MOASSER, Mark M.Journal of clinical oncology. 2014, Vol 32, Num 19, pp 2074-2077, issn 0732-183X, 4 p.Article

ErbB2 Trafificking and Degradation Associated with K48 and K63 PolyubiquitinationMARX, Corina; HELD, Jason M; GIBSON, Bradford W et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 9, pp 3709-3717, issn 0008-5472, 9 p.Article

Clinical relevance of HER-2/neu expression in germ-cell testicular tumorsMANDOKY, Laszlo; GECZI, Lajos; BODROGI, Istvan et al.Anticancer research. 2004, Vol 24, Num 4, pp 2219-2224, issn 0250-7005, 6 p.Article

Immunobiology of Her-2/Neu transgenic micePANNELLINI, Tania; FORNI, Guido; MUSIANI, Piero et al.Breast disease. 2004, Vol 20, pp 33-42, issn 0888-6008, 10 p.Article

Anti-HER2 radioimmunotherapyBRECHBIEL, Martin W; WALDMANN, Thomas A.Breast disease. 2000, Vol 11, pp 125-132, issn 0888-6008Article

Chimeric Rat/Human HER2 Efficiently Circumvents HER2 Tolerance in Cancer PatientsOCCHIPINTI, Sergio; SPONTON, Laura; AMICI, Augusto et al.Clinical cancer research (Print). 2014, Vol 20, Num 11, pp 2910-2921, issn 1078-0432, 12 p.Article

Genetic Ablation of the Fatty Acid―Binding Protein FABP5 Suppresses HER2-Induced Mammary TumorigenesisLEVI, Liraz; LOBO, Glenn; DOUD, Mary Kathryn et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 15, pp 4770-4780, issn 0008-5472, 11 p.Article